ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2245

Vitamin D Deficiency Is Associated with, but Does Not Predict, Change in hsCRP in Systemic Lupus Erythematosus (SLE)

Adnan Kiani, Hong Fang and Michelle Petri, Johns Hopkins University School of Medicine, Baltimore, MD

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Title: Systemic Lupus Erythematosus: Clinical Aspects

Session Type: Abstract Submissions (ACR)

Background/Purpose: In the general population the cardioprotective effects of vitamin D are thought to be due to modulation of inflammatory cytokines.  However, the effects of Vitamin D supplementation on inflammatory biomarkers in various trials have been inconsistent with some trials suggesting a decrease (Am J Clin Nutr 2006:83;754-9) and others finding no effect (Cytokines 2010:50;175-80).  We used the NHANES (National Health and Nutrition Examination Survey) median cut off of Vitamin D at 21.  We then investigated whether vitamin D was associated with or would predict change, in a major inflammatory biomarker, hsCRP, over 2 years in SLE.

Methods: 167 SLE patients (93% female, 63% Caucasian, 32% African-American, mean age 45 yrs) had measurement of hsCRP and 25 hydroxy vitamin D at baseline and at 2 years.  Since distribution of hsCRP was markedly skewed, it was log transformed prior to calculating mean and performing inference.

Results:

There was no difference in hsCRP or Vitamin D levels among patients with different age groups (18-30,31-49,50+) or 25-OH vitamin D levels (<21 and ≥21).  However, Caucasian patients had higher 25 OH vitamin D levels compared to African-Americans (79% vs. 15%, p<0.0001).  At baseline, those with above median Vitamin D had lower hsCRP.  There was a decrease in mean hsCRP in both groups over 2 years, but the difference in change in the two groups was not statistically significant (p=0.78).    

Table : Changes in loge hsCRP levels, by 25-OH Vitamin D level

Measure

Mean at baseline

Mean after

2 years

Mean Change

p-value for change

Difference in change (95% CI)*

p-value for

difference between groups§

 

0.08 (-0.26, 0.41)

0.78

Vitamin D <21 (n=78)

1.31

1.04

-0.29

0.011

Vitamin D ≥21

(n=89)

0.66

0.33

-0.37

0.0041

* Difference in change: measure in vitamin D <21 group minus measure in vitamin D ≥21 group.

§ Adjusted for ethnicity.

 Conclusion: Vitamin D deficiency was associated with higher hsCRP at baseline, but did not predict change of hsCRP over 2 years.  In fact, in contrast to a previous study in the general population (Am J Cardiol 2012:226-30), which showed an increase in hsCRP levels over time with higher vitamin D levels, our study found a reduction in 25-OH vitamin D in this group, as well.  Thus the behavior of vitamin D and hsCRP is different in SLE than in the general population.


Disclosure:

A. Kiani,
None;

H. Fang,
None;

M. Petri,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/vitamin-d-deficiency-is-associated-with-but-does-not-predict-change-in-hscrp-in-systemic-lupus-erythematosus-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology